Publicaciones en colaboración con investigadores/as de Complexo Hospitalario Universitario da Coruña (25)

2020

  1. Prognostic factors in patients with vulvar cancer: The VULCAN study

    International Journal of Gynecological Cancer, Vol. 30, Núm. 9, pp. 1285-1291

2019

  1. Expanded Suitability of Ruptured Abdominal Aortic Aneurysms for Total Endovascular Repair Using the Endurant Endograft and Heli-FX EndoAnchors

    Journal of Endovascular Therapy, Vol. 26, Núm. 2, pp. 245-249

2017

  1. Efficacy and safety of urinary catheters with silver alloy coating in patients with spinal cord injury: a multicentric pragmatic randomized controlled trial. The ESCALE trial

    Spine Journal, Vol. 17, Núm. 11, pp. 1650-1657

  2. Reply

    Journal of Vascular Surgery Cases and Innovative Techniques

2016

  1. Endograft limb trimming and resheathing can be an alternative for emergent aortic repair without adequate stent graft availability

    Journal of Vascular Surgery Cases and Innovative Techniques, Vol. 2, Núm. 3, pp. 88-91

  2. Gender and generations in the appeal of our specialty

    Angiologia

  3. Human immunodeficiency virus infection does not worsen prognosis of liver transplantation for hepatocellular carcinoma

    Hepatology, Vol. 63, Núm. 2, pp. 488-498

  4. Risk profile and secondary prevention in the first visit of intermittent claudication patients to a vascular surgery clinic: ESCUTEPAC study

    Angiologia, Vol. 68, Núm. 4, pp. 276-284

2011

  1. The EORTC tables overestimate the risk of recurrence and progression in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Guérin: External validation of the EORTC risk tables

    European Urology, Vol. 60, Núm. 3, pp. 423-430

2009

  1. A prospective randomized open study in liver transplant recipients: Daclizumab, mycophenolate mofetil, and tacrolimus versus tacrolimus and steroids

    Liver Transplantation, Vol. 15, Núm. 11, pp. 1542-1552

  2. Predicting Nonmuscle Invasive Bladder Cancer Recurrence and Progression in Patients Treated With Bacillus Calmette-Guerin: The CUETO Scoring Model

    Journal of Urology, Vol. 182, Núm. 5, pp. 2195-2203

2008

  1. Prognostic Factors in Patients with Non-Muscle-Invasive Bladder Cancer Treated with Bacillus Calmette-Guérin: Multivariate Analysis of Data from Four Randomized CUETO Trials

    European Urology, Vol. 53, Núm. 5, pp. 992-1002

2007

  1. A Multicentre, Randomised Prospective Trial Comparing Three Intravesical Adjuvant Therapies for Intermediate-Risk Superficial Bladder Cancer: Low-Dose Bacillus Calmette-Guerin (27 mg) versus Very Low-Dose Bacillus Calmette-Guerin (13.5 mg) versus Mitomycin C

    European Urology, Vol. 52, Núm. 5, pp. 1398-1406

  2. European surgeons were the first to perform neck dissection

    Laryngoscope, Vol. 117, Núm. 5, pp. 797-802

2006

  1. Carcinoma fusocelular de cavidad oral. Revisión de 9 casos

    Revista Espanola de Cirugia Oral y Maxilofacial, Vol. 28, Núm. 1, pp. 43-50

  2. Neck dissection: Then and now

    Auris Nasus Larynx, Vol. 33, Núm. 4, pp. 365-374

2005

  1. Has a 3-fold decreased dose of Bacillus Calmette-Guerin the same efficacy against recurrences and progression of T1G3 and Tis bladder tumors than the standard dose? Results of a prospective randomized trial

    Journal of Urology, Vol. 174, Núm. 4 I, pp. 1242-1247

2001

  1. Factors increasing the mortality rate for patients with ruptured abdominal aortic aneurysms

    Annals of Vascular Surgery, Vol. 15, Núm. 6, pp. 601-607

  2. Operative results and death predictors for nonruptured abdominal aortic aneurysms in the elderly

    Annals of Vascular Surgery, Vol. 15, Núm. 3, pp. 306-311

1999

  1. Surgical treatment of ruptured abdominal aortic aneurysms in the elderly

    Annals of Vascular Surgery